TY - JOUR
T1 - Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma
T2 - A study from TARPSWG
AU - van Houdt, Winan J.
AU - Fiore, Marco
AU - Barretta, Francesco
AU - Rutkowski, Piotr
AU - Blay, Jean Yves
AU - Lahat, Guy
AU - Strauss, Dirk
AU - Gonzalez, Ricardo J.
AU - Ahuja, Nita
AU - Grignani, Giovanni
AU - Quagliuolo, Vittorio
AU - Stoeckle, Eberhard
AU - De Paoli, Antonino
AU - Schrage, Yvonne
AU - Cardona, Kenneth
AU - Pennacchioli, Elisabetta
AU - Pillarisetty, Venu G.
AU - Nessim, Carolyn
AU - Swallow, Carol J.
AU - Bagaria, Sanjay P.
AU - Canter, Robert
AU - Mullen, John T.
AU - Callegaro, Dario
AU - Fairweather, Mark
AU - Miceli, Rosalba
AU - Raut, Chandrajit P.
AU - Gronchi, Alessandro
AU - Gladdy, Rebecca A.
N1 - Publisher Copyright:
© 2020 American Cancer Society
PY - 2020/11/15
Y1 - 2020/11/15
N2 - Background: In this series from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), the authors examined longitudinal outcomes of patients with a second recurrence of retroperitoneal sarcoma (RPS) after complete resection of a first local recurrence (LR). Methods: Data from patients undergoing resection of a first LR from January 2002 to December 2011were collected from 22 sarcoma centers. The primary outcome was overall survival (OS) after second recurrence. Results: Second recurrences occurred in 400 of 567 patients (70.5%) after an R0/R1 resection of a first locally recurrent RPS. Patterns of disease recurrence were LR in 323 patients (80.75%), distant metastases (DM) in 55 patients (13.75%), and both LR and DM in 22 patients (5.5%). The main subtype among the LR group was liposarcoma (77%), whereas DM mainly were leiomyosarcomas (43.6%). In patients with a second LR only, a total of 200 patients underwent re-resection (61.9%). The 5-year OS rate varied significantly based on the pattern of failure (P <.001): 45.6% for the LR group, 25.5% for the DM group, and 0% for the group with LR and DM. The only factors found to be associated with improved OS on multivariable analysis were both time between second surgery and the development of the second recurrence (32 months vs 8 months: hazard ratio, 0.44 [P <.001]) and surgery for second recurrence (yes vs no: hazard ratio, 3.25 [P <.001]). The 5-year OS rate for patients undergoing surgery for a second LR was 59% versus 18% in the patients not deemed suitable for surgical resection. Conclusions: Survival rates after second recurrence of RPS varied based on patterns of disease recurrence and treatment. Durable disease-free survivors were identified after surgery for second LR in patients selected for this intervention.
AB - Background: In this series from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG), the authors examined longitudinal outcomes of patients with a second recurrence of retroperitoneal sarcoma (RPS) after complete resection of a first local recurrence (LR). Methods: Data from patients undergoing resection of a first LR from January 2002 to December 2011were collected from 22 sarcoma centers. The primary outcome was overall survival (OS) after second recurrence. Results: Second recurrences occurred in 400 of 567 patients (70.5%) after an R0/R1 resection of a first locally recurrent RPS. Patterns of disease recurrence were LR in 323 patients (80.75%), distant metastases (DM) in 55 patients (13.75%), and both LR and DM in 22 patients (5.5%). The main subtype among the LR group was liposarcoma (77%), whereas DM mainly were leiomyosarcomas (43.6%). In patients with a second LR only, a total of 200 patients underwent re-resection (61.9%). The 5-year OS rate varied significantly based on the pattern of failure (P <.001): 45.6% for the LR group, 25.5% for the DM group, and 0% for the group with LR and DM. The only factors found to be associated with improved OS on multivariable analysis were both time between second surgery and the development of the second recurrence (32 months vs 8 months: hazard ratio, 0.44 [P <.001]) and surgery for second recurrence (yes vs no: hazard ratio, 3.25 [P <.001]). The 5-year OS rate for patients undergoing surgery for a second LR was 59% versus 18% in the patients not deemed suitable for surgical resection. Conclusions: Survival rates after second recurrence of RPS varied based on patterns of disease recurrence and treatment. Durable disease-free survivors were identified after surgery for second LR in patients selected for this intervention.
KW - leiomyosarcoma
KW - liposarcoma
KW - recurrence
KW - retroperitoneal sarcoma
UR - http://www.scopus.com/inward/record.url?scp=85089374505&partnerID=8YFLogxK
U2 - 10.1002/cncr.33139
DO - 10.1002/cncr.33139
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 32797703
AN - SCOPUS:85089374505
SN - 0008-543X
VL - 126
SP - 4917
EP - 4925
JO - Cancer
JF - Cancer
IS - 22
ER -